Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Müschen

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Blood|May 1, 2010
Genetic relicts from the origin of ALLMarkus Müschen
Blood|September 28, 2019
Origins of the human B-cell lineageMarkus Müschen
Nature Reviews. Immunology|March 21, 2019
Metabolic gatekeepers to safeguard against autoimmunity and oncogenic B cell transformationMarkus Müschen
Blood|May 9, 2015
Ph+ ALL: drawing strength from a benign pastMarkus Müschen
Blood|April 17, 2015
Rationale for targeting the pre-B-cell receptor signaling pathway in acute lymphoblastic leukemiaMarkus Müschen
Nature Reviews. Cancer|January 6, 2018
Autoimmunity checkpoints as therapeutic targets in B cell malignanciesMarkus Müschen
Biological Chemistry|August 7, 2008
Highlight: self-renewal signaling in stem cellsMarkus Müschen
Cell Cycle (Georgetown, Tex.)|November 11, 2009
Pre-B cell receptor signaling in acute lymphoblastic leukemiaRahul Nahar, Markus Müschen
Cell Research|December 2, 2017
Portending death in germinal centers - when B cells know their time is upLili Wang, Markus Müschen
Current Opinion in Hematology|May 10, 2014
Targeting the B-cell receptor signaling pathway in B lymphoid malignanciesMaike Buchner, Markus Müschen
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Blood|May 1, 2010
Genetic relicts from the origin of ALLMarkus Müschen
Blood|September 28, 2019
Origins of the human B-cell lineageMarkus Müschen
Nature Reviews. Immunology|March 21, 2019
Metabolic gatekeepers to safeguard against autoimmunity and oncogenic B cell transformationMarkus Müschen
Blood|May 9, 2015
Ph+ ALL: drawing strength from a benign pastMarkus Müschen
Blood|April 17, 2015
Rationale for targeting the pre-B-cell receptor signaling pathway in acute lymphoblastic leukemiaMarkus Müschen
Nature Reviews. Cancer|January 6, 2018
Autoimmunity checkpoints as therapeutic targets in B cell malignanciesMarkus Müschen
Biological Chemistry|August 7, 2008
Highlight: self-renewal signaling in stem cellsMarkus Müschen
Cell Cycle (Georgetown, Tex.)|November 11, 2009
Pre-B cell receptor signaling in acute lymphoblastic leukemiaRahul Nahar, Markus Müschen
Cell Research|December 2, 2017
Portending death in germinal centers - when B cells know their time is upLili Wang, Markus Müschen
Current Opinion in Hematology|May 10, 2014
Targeting the B-cell receptor signaling pathway in B lymphoid malignanciesMaike Buchner, Markus Müschen
Pageof 15